Baylis Medical Technologies today announced it signed a sales and distribution agreement with Oscor.
Through the agreement, Boston Scientific’s Baylis will distribute Oscor’s steerable and guiding sheaths that are currently sold direct-to-hospital. It will allow Baylis to broaden its clinical solution offerings in radiology and vascular surgery.
“This strategic partnership will allow Baylis Medical Technologies to expand our vascular footprint in the United States. It will strengthen our ability to provide current and future customers with dedicated clinical solutions that enable endovascular and other therapies,” Baylis Medical President Kris Shah said in a news release.
Oscor and Baylis have begun the business transfer and will continue to work closely to ensure the transition will have a minimal impact on customers.
Baylis Medical develops and distributes medical products globally.
Oscor’s sheath portfolio will complement the company’s PowerWire RF guidewire, which uses radio frequency technology to enhance the clinical needs of radiologists and vascular surgeons for improved patient care. Medical device contract manufacturing giant Integer acquired Oscor for $220 million in December 2021.